Endeavor

Celebrating 40 Years of Advancing Cancer Care

A look back at the advances that have shaped cancer care at Moffitt and beyond

New Combination Treatment May Help Slow Advanced Melanoma

Adding HBI-8000 to nivolumab delayed melanoma progression in a phase 3 trial

Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence

The results could lead to a change in standard of care pending FDA approval

New FDA-Approved Therapy Offers Hope for Patients With Advanced Melanoma

A first-of-its-kind oncolytic viral immunotherapy combination offers a new option for patients

What To Know About Sunscreen and Skin Cancer Prevention

Experts weigh in on the science behind sunscreen and why broad-spectrum protection matters

Young Melanoma Patient Says Listening to Her Body Saved Her Life

Alexis Cole is encouraging others to be proactive when it comes to protecting their skin and spreading awareness on skin cancer

Popular Sunscreen Ingredient in Europe and Asia Gets FDA Approval

Bemotrizinol is the first new sunscreen ingredient approved in the U.S. in more than 25 years

Study Shows Personalized Vaccine Could Help Prevent Melanoma Recurrence

Five-year data shows the personalized treatment plus immunotherapy lowered disease relapse risk by 49%

Don’t Get Burned by Sun Protection Myths

Moffitt expert debunks common misconceptions that contribute to risky behaviors